ArticleProceedings of the National Academy of Sciences of the United States of America2012

3β-Methoxy-pregnenolone (MAP4343) as an innovative therapeutic approach for depressive disorders.

Massimiliano Bianchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.